Does TREMELIMUMAB Cause Embolism? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Embolism have been filed in association with TREMELIMUMAB (IMJUDO). This represents 1.3% of all adverse event reports for TREMELIMUMAB.
32
Reports of Embolism with TREMELIMUMAB
1.3%
of all TREMELIMUMAB reports
12
Deaths
25
Hospitalizations
How Dangerous Is Embolism From TREMELIMUMAB?
Of the 32 reports, 12 (37.5%) resulted in death, 25 (78.1%) required hospitalization, and 4 (12.5%) were considered life-threatening.
Is Embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB Cause?
Pyrexia (178)
Diarrhoea (136)
Death (116)
Colitis (115)
Pneumonitis (87)
Pneumonia (85)
Sepsis (82)
Vomiting (78)
Febrile neutropenia (72)
Malignant neoplasm progression (68)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which TREMELIMUMAB Alternatives Have Lower Embolism Risk?
TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TREMELIMUMAB vs TRENBOLONE
TREMELIMUMAB vs TREOSULFAN
TREMELIMUMAB vs TREPROSTINIL
TREMELIMUMAB vs TREPROSTINIL DIOLAMINE